# EDGAR Filing Document

**Accession Number:** 0001591986
**File Stem:** 0001085146-25-005456
**Filing Date:** 2025-8
**Character Count:** 5553
**Document Hash:** ca81649ef9495879ca7d2101ca0d026a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005456.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001085146-25-005456

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250822

**EFFECTIVENESS DATE**: 20250822

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aquilo Capital Management, LLC
- **CENTRAL INDEX KEY:** 0001591986

**ORGANIZATION NAME:**
- **EIN:** 272448001
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-18892
- **FILM NUMBER:** 251246298

**BUSINESS ADDRESS:**
- **STREET 1:** ONE LETTERMAN DRIVE
- **STREET 2:** SUITE D4900, BUILDING D
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94129
- **BUSINESS PHONE:** 415-635-0140

**MAIL ADDRESS:**
- **STREET 1:** ONE LETTERMAN DRIVE
- **STREET 2:** SUITE D4900, BUILDING D
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94129

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Aquilo Capital Managment, LLC
- **DATE OF NAME CHANGE:** 20131114

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001591986

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Aquilo Capital Management, LLC

**Address:** ONE LETTERMAN DRIVE, SAN FRANCISCO, CA 94129

**Telephone number:** 415-635-0140

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-18892

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 254900J03UBQSFDMNU40

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                  | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                   | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | 03/12/2025     | Advisory Vote to Approve Executive Compensation.                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | 03/12/2025     | Advisory Vote on Frequency of Executive Compensation Advisory Votes.                                                                               | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| BLUEPRINT MEDICINES CORPORATION | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                  | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| PRECISION BIOSCIENCES, INC.     | 74019P207 | 05/28/2025     | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers (commonly referred to as the "say-on-pay vote"). | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| PRECISION BIOSCIENCES, INC.     | 74019P207 | 05/28/2025     | Approval, on an advisory (non-binding) basis, of the frequency of future say-on-pay votes.                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |
| REPARE THERAPEUTICS INC.        | 760273102 | 06/17/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the accompanying proxy statement.              | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | ABSTAIN     |                                        0 | NONE                        |  |

## N-PX: Signature Block

**Reporting Person:** Aquilo Capital Management, LLC

**By (Signature):** Marc Schneidman

**By (Printed Signature):** Marc Schneidman

**By (Title):** Managing Member

**Date:** 08/22/2025